Raymond James Financial Services Advisors’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
2018
Q1
$123K Buy
2017
Q4
$15K Hold
2017
Q3
$39K Sell
2017
Q2
$82K Hold
2017
Q1
$147K Buy